Identity and localization of advanced glycation end products on human β2-microglobulin using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
- 6 March 2003
- journal article
- research article
- Published by Elsevier in Analytical Biochemistry
- Vol. 314 (2) , 322-325
- https://doi.org/10.1016/s0003-2697(02)00690-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Protein GlycationAnnals of the New York Academy of Sciences, 2001
- Influence of hemodialysis membrane type on pentosidine plasma level, a marker of “carbonyl stress”Kidney International, 1999
- Impaired lysosomal processing of β2-microglobulin by infiltrating macrophages in dialysis amyloidosisKidney International, 1999
- Alterations of synovial tissue and their potential role in the deposition of beta2-microglobulin-associated amyloidNephrology Dialysis Transplantation, 1998
- β2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblastsKidney International, 1998
- Histological prevalence of β2-microglobulin amyloidosis in hemodialysis: A prospective post-mortem studyKidney International, 1997
- β2-Microglobulin Dialysis Amyloid and Its Formation: Role of 3-Deoxyglucosone and Advanced Glycation End ProductsNephron, 1997
- β2-Microglobulin Modified with Advanced Glycation End Products Induces Interleukin-6 from Human Macrophages: Role in the Pathogenesis of Hemodialysis-Associated AmyloidosisBiochemical and Biophysical Research Communications, 1994
- Cells surrounding haemodialysis-associated amyloid deposits are mainly macrophagesNephrology Dialysis Transplantation, 1994
- beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.Journal of Clinical Investigation, 1993